FDA Approves Generic of Xyrem With REMS Program; Jazz Pharmaceuticals (JAZZ) Shares Decline
Tweet Send to a Friend
(Updated - January 17, 2017 4:39 PM EST)Jazz Pharmaceuticals (NASDAQ: JAZZ) declined post-market Tuesday after the FDA approved generic Xyrem.From ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
